Objective: Genetic associations and blockade of the interleukin-23/IL-17 axis with monoclonal antibodies support a role for this pathway in psoriatic arthritis (PsA). This study examines the requirement of IL-23 for IL-17 production, and the role of the metabolic microenvironment in the expansion of Th17-derived cells in PsA.
Methods: PsA patient synovial fluid or peripheral blood Th17 cell frequencies were evaluated by flow cytometry using CCR6, CD161 and T-bet as phenotypic markers, and the cytokines IFN-γ, GM-CSF and IL-17 assessed by flow cytometry and ELISA. The impact of IL-23 and metabolic stress on T cell differentiation was investigated.
Results: Polyfunctional IL-17pos CD4 (p<0.0001) & CD8 (p<0.0001), and GM-CSFpos Th17-derived (p<0.0001) cells were increased in inflamed joints of patients with PsA, with a proportional decrease in patient peripheral blood. We demonstrate IL-23-independent IL-17 release by PsA patient CD4 T cells, where the absence of IL-23 during Th17 differentiation reduced IL-17 by 31±5.8%. Exogenous IL-23 increased IL-17, negatively regulated GM-CSF and co-operated with TGF-β to augment IL-17. Polyfunctional Th17 and Th17-derived cells, but not Th1 cells, were expanded by metabolic stress in patients with PsA.
Conclusions: We confirmed the abundance of polyfunctional Type17 CD4 and CD8 cells in PsA inflamed joints. We demonstrate IL-23-independent expansion of Th17 cells, where IL-23 negatively regulates GM-CSF. This may account for therapeutic differences in IL-17 and IL-23 inhibition in PsA and the Spondyloarthritides. Polyfunctional IL-17pos Th17, and Th17-derived but not Th1 cells, were expanded by metabolic stress, where metabolic stress may itself represent a unique therapeutic target.
This article is protected by copyright. All rights reserved.